Variant report
Variant | nsv550967 |
---|---|
Chromosome Location | chr10:56301550-56321182 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188182405 | chr10:56309687-56309688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530371744 | chr10:56309710-56309711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540478124 | chr10:56309767-56309768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534010660 | chr10:56309799-56309800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1219795 | chr10:56309812-56309813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9787572 | chr10:56309825-56309826 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs552327429 | chr10:56309863-56309864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544199156 | chr10:56309948-56309949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375052790 | chr10:56309978-56309979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138033104 | chr10:56310009-56310010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs180982135 | chr10:56310042-56310043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs142011864 | chr10:56310044-56310045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574580378 | chr10:56310080-56310081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs61853622 | chr10:56310116-56310117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547292613 | chr10:56310117-56310118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559631332 | chr10:56310128-56310129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185646661 | chr10:56310130-56310131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570598026 | chr10:56310158-56310159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539235242 | chr10:56310168-56310169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558661571 | chr10:56310177-56310178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs114650311 | chr10:56310181-56310182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537850639 | chr10:56310206-56310207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201576041 | chr10:56310248-56310249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566291877 | chr10:56310249-56310250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs59286214 | chr10:56310268-56310269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71010384 | chr10:56310269-56310270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs9787425 | chr10:56310279-56310280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150457941 | chr10:56310286-56310287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540892471 | chr10:56310295-56310296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560599094 | chr10:56310297-56310298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113245777 | chr10:56310319-56310320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190412316 | chr10:56310323-56310324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138265340 | chr10:56310352-56310353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149652681 | chr10:56310361-56310362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546408962 | chr10:56310398-56310399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562618026 | chr10:56310431-56310432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115582503 | chr10:56310447-56310448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11004378 | chr10:56310482-56310483 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs561693753 | chr10:56310494-56310495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs527614251 | chr10:56310525-56310526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs115614240 | chr10:56310535-56310536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144378424 | chr10:56310564-56310565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs147566875 | chr10:56310590-56310591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs375436565 | chr10:56314431-56314432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556562725 | chr10:56314475-56314476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2384471 | chr10:56314480-56314481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs191493288 | chr10:56314493-56314494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536230753 | chr10:56314505-56314506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553035903 | chr10:56314539-56314540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1930142 | chr10:56314548-56314549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Melanoma | 17363583 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56309600-56310600 | Enhancers | HUVEC | blood vessel |
2 | chr10:56314400-56315000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr10:56317000-56317400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr10:56317400-56319000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr10:56319000-56320000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr10:56319200-56320000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |